Ausgabe 2/2015
Inhalt (17 Artikel)
Tumor bed radiosurgery: an emerging treatment for brain metastases
Mark J. Amsbaugh, Warren Boling, Shiao Woo
miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients
Johnny C. Akers, Valya Ramakrishnan, Ryan Kim, Shirley Phillips, Vivek Kaimal, Ying Mao, Wei Hua, Isaac Yang, Chia-Chun Fu, John Nolan, Ichiro Nakano, Yuanfan Yang, Martin Beaulieu, Bob S. Carter, Clark C. Chen
Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells
George A. Alexiou, Konstantinos I. Tsamis, Evrysthenis Vartholomatos, Evangelia Peponi, Eftychia Tzima, Ifigeneia Tasiou, Efstathios Lykoudis, Pericles Tsekeris, Athanasios P. Kyritsis
Novel anti IGFBP2 single chain variable fragment inhibits glioma cell migration and invasion
Shilpa S. Patil, Reema Railkar, Monalisa Swain, Hanudatta S. Atreya, Rajan R. Dighe, Paturu Kondaiah
Stereotactic radiosurgery in combination with up-front high-dose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphoma
Seiichiro Hirono, Yasuo Iwadate, Yoshinori Higuchi, Toru Serizawa, Osamu Nagano, Tomoro Matsutani, Naokatsu Saeki
Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy
Kim Kramer, Neeta Pandit-Taskar, Pat Zanzonico, Suzanne L. Wolden, John L. Humm, Carl DeSelm, Mark M. Souweidane, Jason S. Lewis, Nai-Kong V. Cheung
Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials
Julie A. Carlson, Krishna Reddy, Laurie E. Gaspar, Douglas Ney, Brian D. Kavanagh, Denise Damek, Kevin Lillehei, Changhu Chen
BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial
Stuart H. Burri, Roshan S. Prabhu, Ashley L. Sumrall, Wendy Brick, Brian D. Blaker, Brent E. Heideman Jr., Peggy Boltes, Renee Kelly, James T. Symanowski, Walter F. Wiggins, Lynn Ashby, H. James Norton, Kevin Judy, Anthony L. Asher
Which one is a valuable surrogate for predicting survival between Tomita and Tokuhashi scores in patients with spinal metastases? A meta-analysis for diagnostic test accuracy and individual participant data analysis
Chang-Hyun Lee, Chun Kee Chung, Tae-Ahn Jahng, Ki-jeong Kim, Chi Heon Kim, Seung-Jae Hyun, Hyun-Jib Kim, Sang Ryong Jeon, Ung-Kyu Chang, Sun-Ho Lee, Seong-Hwan Moon, Haroon Majeed, Dan Zhang, Gwenaelle Gravis, Christine Wibmer, Naresh Kumar, Kyung Yun Moon, Jin Hoon Park, Emeline Tabouret, Stephane Fuentes
Phase II pilot study of single-agent etirinotecan pegol (NKTR-102) in bevacizumab-resistant high grade glioma
Seema Nagpal, Cathy Kahn Recht, Sophie Bertrand, Reena Parada Thomas, Abdulrazag Ajlan, Justine Pena, Megan Gershon, Gwen Coffey, Pamela L. Kunz, Gordon Li, Lawrence D. Recht
Calcification in high grade gliomas treated with bevacizumab
Deborah T. Blumenthal, Orna Aisenstein, Idan Ben-Horin, Dafna Ben Bashat, Moran Artzi, Benjamin W. Corn, Andrew A. Kanner, Zvi Ram, Felix Bokstein
MRI findings and pathological features in early-stage glioblastoma
Makoto Ideguchi, Koji Kajiwara, Hisaharu Goto, Kazutaka Sugimoto, Sadahiro Nomura, Eiji Ikeda, Michiyasu Suzuki
Age-associated brain regions in gliomas: a volumetric analysis
Yinyan Wang, Shuai Liu, Xing Fan, Shaowu Li, Renzhi Wang, Lei Wang, Jun Ma, Tao Jiang, Wenbin Ma
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival
Marcos A. dos Santos, Jean-Pierre Pignon, Pierre Blanchard, Delphine Lefeuvre, Antonin Levy, Mehdi Touat, Guillaume Louvel, Frédéric Dhermain, Jean-Charles Soria, Eric Deutsch, Gwénaël Le Teuff
Opsoclonus-myoclonus syndrome in a patient with an anaplastic oligoastrocytoma
Carl A. Gold, Andrew B. Lassman, Yazmín Odia
Influence of 1p19q status and Ki67 index to predict extent of resection in WHO grade II gliomas: a virtual patient model
Dominik Cordier, Sabine Schädelin, Hugues Duffau
SmART-ER imaging and treatment of glioblastoma
Patrick V. Granton, Sanaz Yahyanejad, Marc A. Vooijs